First Turn Management »

Harrow Health shares owned by First Turn Management

Quarter-by-quarter ownership of Harrow Health (HROW) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Harrow Health

Tip: Access up to 7 years of quarterly data

All positions including Harrow Health held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harrow Health by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $15M 327k 44.96

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Harrow Health

Opaleye Management
Private Capital Management
BlackRock
BlackRock
Vanguard Group
Susquehanna International
Geode Capital Management
State Street Corporation
Citadel Advisors
Stifel Financial
Nuveen Asset Management
Royce & Associates
First Turn Management
Rice Hall James & Associates
Braidwell

View all funds holding Harrow Health